Lauren Wood
CIK 1769757 · View on SEC EDGAR ↗
First SEC filing: June 7, 2019 · Latest: June 7, 2019
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Jan. 5, 2023 | PDSB | A | 110,800 | — | — | 110,800 Direct | — | Acquired | (price as of 2026-08-21) |
| Jan. 19, 2022 | PDSB | A | 88,600 | — | — | 88,600 Direct | — | Acquired | (price as of 2026-08-21) |
| Dec. 8, 2020 | PDSB | A | 210,500 | — | — | 210,500 Direct | — | Acquired | (price as of 2026-08-21) |
| June 23, 2020 | PDSB | A | 35,000 | — | — | 35,000 Direct | — | Acquired | (price as of 2026-08-21) |
| June 6, 2019 | PDSB | A | 62,715 | — | — | 62,715 Direct | — | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 5, 2023 | PDSB | Employee Stock Option (Right to Buy) | Common Stock (110,800) | $11.61 | Jan. 5, 2033 | 110,800 | Acquired |
| Jan. 19, 2022 | PDSB | Employee Stock Option (Right to Buy) | Common Stock (88,600) | $6.28 | Jan. 19, 2032 | 88,600 | Acquired |
| Dec. 8, 2020 | PDSB | Stock Option (Right to Buy) | Common Stock (210,500) | $2.43 | Dec. 8, 2030 | 210,500 | Acquired |
| June 23, 2020 | PDSB | Employee Stock Option (Right to Buy) | Common Stock (35,000) | $1.45 | June 23, 2030 | 35,000 | Acquired |
| June 6, 2019 | PDSB | Stock Option (Right To Purchase) | Common Stock (62,715) | $6.39 | June 6, 2029 | 62,715 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
PDSB
M.D.(3) Former Chief Medical Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2023 | $428,000 | — | — | $1,195,532 | — | — | $9,967 | $1,633,499 |
| 2022 | $400,000 | $160,000 | — | $440,250 | — | — | $8,500 | $1,008,750 |
| 2021 | $335,000 | $108,875 | — | $1,885,153 | — | — | $1,117 | $2,330,145 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.